samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

SHL attends the 2020 PDA in virtual fashion

SHL Group


SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform. Visitors can attend the event through the PDA’s online platform that comprises live chat sessions, conference presentations, and company pages.

In line with PDA’s digitalized strategy and in response to many inquiries from our partners and customers who have not been able to visit the SHL site due to this year’s special circumstances, SHL will also launch a webpage titled The SHL Experience to showcase the processes behind the making of our devices. The SHL Experience is rich with informative content and interactive elements, boasting our capabilities in fine machinery and expertise, while detailing our end-to-end processes, from design and development to mass production and quality control. Also, the webpage features a sophisticated design as well as a simple and intuitive interface that allows users to navigate its contents easily.

Global marketing director Magnus Fastmarken said, “The current state of the global pandemic has determined the course of digital marketing, driving companies to find new tools for effective communication with customers or business partners. For SHL, staying at the forefront of industry trends not only means providing our customers with the best products, but also finding the best way to communicate with them. SHL is poised for this new normal era.”

In addition to the premier of our virtual experience webpage, SHL experts will also give a total of four presentations while our partners at Innovation Zed will present a poster presentation at the online conference. Interested participants will have the opportunity to join our speakers at the live Q&A during the given time (EDT) for each session as follows:

 

 

Topic

Speaker

Time

Customizing Platform Devices: A Review of Molly’s Flexible Design and Development Model

Josh Gonzalez, Chief Commercial Officer, 

SHL Medical

Oct 6

11:00 am – 11:15 am Tech Talk

Characterization of a Novel Mini Bag Primary Packaging Technology

Hans Peter Manser, Senior Director of Business Development, SHL Medical 

 

Christoph Egloff, Senior Manager of Innovation and Development, SHL Medical 

Oct 7

Session A3

11:35 am – 11:55 am 

 

From Self-Administration to Self-Management:

A Digital Health Reformulation for the Drug Delivery Industry

Ramin Rafiei Ph.D., Director of Digital Healthcare, SHL Medical

Rasmus Renstad Ph.D., Director of Innovation, SHL Medical

 

Oct 7

Session C3

11:35 am – 11:55 am

 

Case Study: Key Transformation Considerations for the Design, Development, and Manufacturing of Connected Devices

Dewi Kodrat, Manager of Engineering Solutions, SHL Medical 

 

Oct 8

Session P4

10:00 am – 10:20 am 

 

Poster Presentation-Insulcheck Connect

Dean Minnock, CEO, Innovation Zed

 

Oct 5-8

12:15 pm – 2:30 pm

 Visitors are also encouraged to check into the chatroom to speak with SHL experts about our products or company information. Our experts will be standing by to answer visitors’ questions. To access The SHL experience, click here.

phone +886 3 217 0303
email info@shl-group.com
web www.shl.group
email No.136 Kuo Sheng 2nd Street, Taoyuan, Taiwan, 330
 
Print this page
Send to a friend
   
spacer
News and Press Releases

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS


More info >>


White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement